Specialty Pharmacy Insights

At Avella, we take pride in our dedication to patients above all else. This extends far beyond dispensing life-saving medications and into providing specialized, compassionate care in an effort to touch and improve as many lives as we can. Our ...

Would you be surprised to hear that two out of three people with invasive cancer are living 5 years or longer -- nearly 30% more than 49% in 1975? Clinical trial activity for oncology research also climbed more than 10% last year. Cancer care these ...

The American Cancer Society recognizes February as National Cancer Prevention Month. In honor of this month, we are sharing three ways you and your family can help reduce your risk of cancer or detect cancer earlier. Let's start with the simple ...

Since 1970, the American Red Cross has recognized January as National Blood Donor Month. According to the Red Cross, blood donation drops during the winter because weather often restricts the ability to host a blood drive, or potential donors are ...

This week, the FDA granted accelerated approval to Rubraca™ (rucaparib), an oral therapy for patients with advanced ovarian cancer who have been treated with two or more chemotherapies and whose tumors have deleterious BRCA gene mutation as ...

We are excited to announce that Avella has recently acquired Oncology Plus, LLC, a leading provider of patient-specific compounded therapies to oncology practices, hospitals and payors nationwide. With this acquisition, Avella furthers its strategic ...

According to the Network for Excellence in Health Innovation, in the United States, poor medication adherence alone accounts for $290 billion of the annual $750 billion in wasted healthcare spend. In addition, medication non-adherence with complex ...

Avella is focused on delivering the most relevant tools and information to our providers and their patients. We are excited to share with you our fifth edition of Dispensing Excellence, a publication for healthcare providers, nurses, medical ...

In the past two years alone, 25 new oncology medications have been approved by the FDA. That's the good news. The challenge is that staying up to date with all of the latest information about these drugs takes a lot of your time...time that could be ...